“…Artonin E, also known as 5′-hydroxymorusin, possesses a flavonoid skeleton linked to a lipophilic prenyl side chain. Initially detected in the bark of AA, this molecule has been widely explored for its varied pharmacological activities, encompassing antibacterial, anticancer, antiestrogenic, anti-FAT10, antimalarial, antinephritis, antioxidant, and antiplasmodial activities . The anticancer effects of Artonin E have been explored across diverse cancer cell types, including breast (MCF-7, MDA-MB-231), , colon (LoVo, HCT116), , gastric cancers (AGS), leukemia (P-388), lung (H460, H23, H292, A549), , and ovarian (SKOV3, 1A9). , These studies highlight the potential of artonin E in inducing apoptosis, anoikis, and cell-cycle arrest and inhibiting proliferation, invasion, migration, and overcoming resistance to the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). – The underlying mechanisms involve activation and suppression of proapoptotic and antiapoptotic proteins, respectively.…”